CD44 Splice Variant Expression in Clear Cell Carcinoma of the Ovary

By Rodriguez-Rodriguez L.   Sancho-Torres I.   Leakey P.   Gibbon D.G.   Comerci J.T.   Ludlow J.W.   Mesonero C.  

Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. : 223-229

Elsevier

Access to resources Recommend Favorite

Clinical Characteristics of Clear Cell Carcinoma of the Ovary

By Behbakht K.   Randall T.C.   Benjamin I.   Morgan M.A.   King S.   Rubin S.C.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 255-258

Elsevier

Access to resources Recommend Favorite

CD44 is associated with tumor recurrence and is an independent poor prognostic factor for patients with localized clear cell renal cell carcinoma after nephrectomy

By Jeong Byung-Joo   Liang Zhe Long   Huang Song Mei   Lim Jae Sung   Kim Jin Man   Lee Hyo Jin  

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-05 ,pp. : 811-817

Spandidos Publications

Access to resources Recommend Favorite

CD44 Isoform 6 (CD44v6) Is a Prognostic Indicator of the Response to Neoadjuvant Chemotherapy in Cervical Carcinoma

By Costa S.   Terzano P.   Bovicelli A.   Martoni A.   Angelelli B.   Santini D.   Ceccarelli C.   Lipponen P.   Erzen M.   Syrjanen S.   Syrjanen K.  

Gynecologic Oncology, Vol. 80, Iss. 1, 2001-01 ,pp. : 67-73

Elsevier

Access to resources Recommend Favorite

Blindness as a Consequence of a Paraneoplastic Syndrome in a Woman with Clear Cell Carcinoma of the Ovary

By Donovan J.T.   Prefontaine M.   Gragoudas E.S.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 424-429

Elsevier

Access to resources Recommend Favorite